Scribe Therapeutics
CA, United States
Senior Research Associate I/II, Discovery, Genome editing
Scribe Therapeutics is a molecular engineering company focused on creating best-in-class in vivo therapies that permanently treat the underlying cause of disease. Founded by CRISPR inventors and leading molecular engineers Benjamin Oakes, Brett Staahl, David Savage, and Jennifer Doudna, Scribe is overcoming the limitations of current genome editing technologies by developing custom engineered enzymes and delivery modalities as part of a proprietary, evergreen CRISPR by Design™ platform for CRISPR-based genetic medicine.
We are seeking a highly creative, passionate, and motivated individual to join us in our quest to develop the next generation of CRISPR-based therapeutics. The current role is for a Senior Research Associate to advance our ongoing efforts to develop therapeutics for neurodegenerative disorders . The candidate should have a passion for characterizing the CRISPR systems that advance our therapeutic programs. The role will work collaboratively across interdisciplinary teams, including protein engineers, process sciences, computational biologists, NGS, and disease experts. The candidate should bring experience in molecular biology, cell culture, and a passion for creating tools to meet the challenge of this new frontier in genetic medicine.
The candidate will have numerous opportunities for professional growth in a rapidly growing biotechnology start-up, which includes growing into a role of increasing responsibilities and the ability to publish highly impactful work in peer reviewed journals.
Key Responsibilities:
Required Skills and Background:
This job is not in any teams
This job is not in any offices
Scribe Therapeutics
1 followers
Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.